LAXMI SANKALPA BHAGANAGARAPU and SARUMATHY SUNDARARAJAN, “NOVEL APPROACHES FOR ANEMIA IN CARDIORENAL SYNDROME: A RANDOMIZED CONTROLLED TRIAL OF HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR VS SGLT2 INHIBITOR”, Asian J Pharm Clin Res, vol. 18, no. 12, pp. 184–191, Dec. 2025.